- Home
- CELC vs BAND Comparison
CELC vs BAND Comparison
Compare CELC & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- BAND
- Stock Information
- Founded
- CELC 2011
- BAND 2000
- Country
- CELC United States
- BAND United States
- Employees
- CELC N/A
- BAND N/A
- Industry
- CELC Medical Specialities
- BAND Computer Software: Prepackaged Software
- Sector
- CELC Health Care
- BAND Technology
- Exchange
- CELC Nasdaq
- BAND Nasdaq
- Market Cap
- CELC 440.0M
- BAND 473.2M
- IPO Year
- CELC 2017
- BAND 2017
- Fundamental
- Price
- CELC $55.07
- BAND $16.94
- Analyst Decision
- CELC Strong Buy
- BAND Buy
- Analyst Count
- CELC 5
- BAND 6
- Target Price
- CELC $53.60
- BAND $20.80
- AVG Volume (30 Days)
- CELC 862.3K
- BAND 240.8K
- Earning Date
- CELC 11-13-2025
- BAND 10-30-2025
- Dividend Yield
- CELC N/A
- BAND N/A
- EPS Growth
- CELC N/A
- BAND N/A
- EPS
- CELC N/A
- BAND N/A
- Revenue
- CELC N/A
- BAND $758,106,000.00
- Revenue This Year
- CELC N/A
- BAND $2.48
- Revenue Next Year
- CELC N/A
- BAND $13.24
- P/E Ratio
- CELC N/A
- BAND N/A
- Revenue Growth
- CELC N/A
- BAND 14.51
- 52 Week Low
- CELC $7.58
- BAND $11.33
- 52 Week High
- CELC $63.06
- BAND $23.00
- Technical
- Relative Strength Index (RSI)
- CELC 59.21
- BAND 70.10
- Support Level
- CELC $50.44
- BAND $14.97
- Resistance Level
- CELC $63.06
- BAND $16.49
- Average True Range (ATR)
- CELC 3.03
- BAND 0.64
- MACD
- CELC -0.90
- BAND 0.19
- Stochastic Oscillator
- CELC 44.24
- BAND 94.80
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.